Menstrual Migraine study: Rimegepant
Official title A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
ClinicalTrials.gov ID: NCT06641466
What this study is testing
What is Rimegepant?
An investigational oral dissolving tablet being studied for the prevention of menstrual migraine attacks.
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether rimegepant can help stop migraines that happen around a woman’s period. It also looks at how safe the medicine is.
- Who it's for
- You may be able to join if you are a woman who gets migraines around your period.
- What's involved
- You will take rimegepant during the time around your period. You will keep a diary of your migraines and any side effects.
- Time commitment
- The study lasts a few months and you will have several visits to the clinic to give your diary and discuss your health.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, women only
You may be able to join if
- Participant has regular menstrual cycles ≥24 days and ≤34 days
- A minimum 1-year history of migraine (with or without aura) consistent with a diagnosis according to the International Classification of Headache...
- A history of menstrual migraine attacks of at least 3 months
- Participant reported history of experiencing at least 1 migraine attack during the perimenstrual period in at least 2 out of 3 menstrual cycles...
- If the participant is receiving a permitted background continuous prophylactic migraine medication, the medication dose must be stable for at least 3...
You likely can't join if
- Greater than 6 migraine days per month that are outside of the perimenstrual period in the 3 months prior to Screening
- A diagnosis of chronic migraine or a history of more than 14 headache days per month on average, in the 3 months prior to Screening
- History of retinal migraine, basilar migraine or hemiplegic migraine
- Current diagnosis of schizophrenia, bipolar, or borderline personality disorder
- Other pain syndromes (eg, fibromyalgia, complex regional pain syndrome), or significant neurological disorders (other than migraine), or other...
The study team makes the final eligibility decision.
Where it is enrolling
- Phoenix, Arizona, United States
- Scottsdale, Arizona, United States
- Canoga Park, California, United States
- Colton, California, United States
- Walnut Creek, California, United States
- Aventura, Florida, United States
- Hallandale, Florida, United States
- Jacksonville, Florida, United States
- Marietta, Georgia, United States
- Stockbridge, Georgia, United States
- Meridian, Idaho, United States
- Evansville, Indiana, United States
- Ann Arbor, Michigan, United States
- Springfield, Missouri, United States
- Weldon Spring, Missouri, United States
- Papillion, Nebraska, United States
- Las Vegas, Nevada, United States
- Rochester, New York, United States
- The Bronx, New York, United States
- Durham, North Carolina, United States
+ 90 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Phoenix, Arizona, United States; Scottsdale, Arizona, United States; Canoga Park, California, United States; Colton, California, United States; Walnut Creek, California, United States; Aventura, Florida, United States and 104 more locations. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.